Cartalax 20mg

Format: Lyophilized research material in a sealed vial
Labelled amount: 20mg per vial
Quantity options: 1, 2, 5 or 10 vials
Use classification: Laboratory research only
Packaging note: Cap colour may vary by batch

Cartalax is a synthetic tripeptide with the sequence Ala-Glu-Asp, also known as AED or T-31. It is catalogued for controlled laboratory studies of cartilage biology, connective-tissue signalling and extracellular-matrix regulation. Published research is primarily preclinical and does not establish clinical efficacy. See the product resources below for related research context and sources.

Add 2 mL of bacteriostatic water to the vial. This creates a solution that is 10 mg/mL. On a U-100 syringe, 10 units equals 0.1 mL, which contains 1 mg of active material.

Store lyophilized vials in a cool, dry, dark location until ready for laboratory use. Keep vials sealed and protected from moisture, direct light, and unnecessary temperature fluctuation. After reconstitution, store refrigerated unless your validated protocol specifies otherwise. Minimize repeated warming and cooling, avoid repeated freeze-thaw cycles, and label prepared vials with the preparation date and concentration.

Orders ship from Canadian inventory to eligible Canadian addresses. Tracking is provided after dispatch; transit time varies by route and carrier.

Supplier-provided reports are published for selected products and strengths in the Certificates library. Each report identifies the tested sample strength and measured results.

How to read an analytical report